Dana Farber’s multi-billion-dollar funding move signals a new era in advanced healthcare infrastructure
Boston, United States, 4 May 2026 – A leading cancer research and treatment institution is taking a significant step toward expanding its facilities and enhancing patient care....
Manganese-based breakthrough aims to make medical scans safer and more accessible
Chalfont St Giles, England, 27 April 2026 – A major step forward in medical imaging is underway as GE HealthCare begins advanced clinical trials of a new MRI contrast...
ADB-backed funding to upgrade hospitals, expand digital care, and strengthen treatment across the Pacific island nation
Suva, Fiji, 20 April 2026 – Fiji’s healthcare system is set for a major upgrade after the Asian Development Bank approved a $50 million...
A growing number of people are relying on artificial intelligence for medical advice, raising both convenience and safety concerns
Washington, D.C., 13 April 2026 – Artificial intelligence is quickly becoming a go-to tool for everyday decisions, including health. A recent...
Imagine preparing for a contract negotiation where every team believes they are right. Finance presents one view of reimbursement performance. Clinical leadership brings forward the realities of care delivery. Operations focuses on throughput constraints and staffing pressures. Each perspective...
In the modern healthcare ecosystem, the transition from traditional fee-for-service models to value-based care (VBC) has historically been stymied by fragmented data, siloed workflows, and immense administrative burdens. The promise of VBC – better clinical outcomes, lower operational costs,...
Revenue cycle management (RCM) has evolved far beyond billing and collections in today’s healthcare environment, becoming a powerful determinant for efficient healthcare systems. Its processes are directly tied to sustainable financial outcomes, operational capacity, and how patients experience the...
Introduction: The Access Paradox in Cell & Gene Therapy
Regulatory approval is a critical milestone, but it is not synonymous with patient access. Globally, developers are increasingly encountering situations where approved therapies see limited uptake due to operational complexity, insufficient...
